Epilepsy Trial, Recruiting (NCT06334029)

Epilepsy Trial, Recruiting NCT06334029 Sponsor: IRCCS Eugenio Medea Condition: Epilepsy

Printed from Voxsanity (voxsanity.com.au) — NCT06334029 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Epilepsy

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have been diagnosed with focal or generalized epilepsy, confirmed by a specialist.
People who have had at least one MRI brain scan that includes a type of image called a T1-weighted (T1w) scan.
People who have had at least one resting-state EEG recording (a brain wave test done while sitting quietly).
People who are between 6 and 65 years old at the time of the study evaluation.
People who are able to participate in a neuropsychological assessment (a series of tests that look at thinking, memory, and behaviour).

Who may not be able to join:

People whose epilepsy is caused by blood vessel problems or by brain tumours that are not classified as low grade.
People who are younger than 6 or older than 65 years of age.
People whose brain imaging (neuroradiological) examination is incomplete.
People who do not have a resting-state EEG recording available.
People who are unable to participate in a neuropsychological evaluation.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 22 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Gian Marco Duma, PhD, IRCCS E. Medea

Phone: +39 0438414248

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06334029

Sponsor: IRCCS Eugenio Medea

Phase: Not Applicable

Status: Recruiting

Condition: Epilepsy

Trial contact: +39 0438414248

More information: https://clinicaltrials.gov/study/NCT06334029

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have been diagnosed with focal or generalized epilepsy, confirmed by a specialist.
People who have had at least one MRI brain scan that includes a type of image called a T1-weighted (T1w) scan.
People who have had at least one resting-state EEG recording (a brain wave test done while sitting quietly).
People who are between 6 and 65 years old at the time of the study evaluation.
People who are able to participate in a neuropsychological assessment (a series of tests that look at thinking, memory, and behaviour).

Who may not be able to join:

People whose epilepsy is caused by blood vessel problems or by brain tumours that are not classified as low grade.
People who are younger than 6 or older than 65 years of age.
People whose brain imaging (neuroradiological) examination is incomplete.
People who do not have a resting-state EEG recording available.
People who are unable to participate in a neuropsychological evaluation.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 22 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

IRCCS Eugenio Medea

Registry

ClinicalTrials.gov

Start date

22 June 2023

Est. completion

22 November 2026

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Identification of regional alteration in the value of functional connectivity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov